Catalog No.
Product Name
Application
Product Information
Citations
-
Uridine Analog
2’,3’-Di-O-isopropylidene-4’-alpha-C-azidouridine is a uridine analog that serves as a valuable tool in the study of anticonvulsant and anxiolytic properties, with potential applications in developing antihypertensive agents. This compound features an azide group, enabling it to function as a click chemistry reagent through copper-catalyzed azide-alkyne cycloaddition (CuAAc) reactions with alkyne-containing molecules. Additionally, it can participate in strain-promoted alkyne-azide cycloaddition (SPAAC) with DBCO or BCN functionalized compounds, facilitating bioconjugation and tracer development in chemical biology. -
Adenosine Analog
N6-Benzyl-2’-C-methyladenosine is an adenosine analog that primarily targets adenosine receptors. This compound exhibits vasodilatory effects in smooth muscle and demonstrates potential in inhibiting cancer progression. It serves as a valuable tool in studies focusing on cardiovascular function and cancer biology, facilitating research into therapeutic strategies for related conditions. -
Purine Nucleoside Analog
2'-Deoxy-2'-fluoro-3',5'-bis-O-TBDMS-uridine is a purine nucleoside analog with significant antitumor activity. It primarily targets indolent lymphoid malignancies by inhibiting DNA synthesis and inducing apoptosis. This compound serves as a valuable reagent for research applications focused on cancer biology and therapeutic development. -
Purine Nucleoside Analog
2',3'-Didehydro-2',3'-dideoxyuridine is a purine nucleoside analog that exhibits significant antitumor properties, particularly in the treatment of indolent lymphoid malignancies. Its primary mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis. This compound serves as a valuable tool for research applications focused on cancer biology and therapeutic development. -
Purine Nucleoside Analog
N6-Dimethyldeoxyadenosine is a purine nucleoside analog that exhibits broad antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanism involves the inhibition of DNA synthesis and the induction of apoptotic pathways in cancer cells. This compound serves as a valuable tool in cancer research, contributing to the development of therapeutic strategies targeting malignant lymphoid tissues. -
Product of Ergothionase
Thiourocanic acid is a metabolite resulting from the enzymatic activity of ergothionase on the substrate ergothioneine. This compound has been studied for its potential biological activities, including antioxidant properties. It serves as a useful tool in research exploring the metabolic pathways of thiol compounds and their roles in cellular protection and oxidative stress responses. -
Purine Nucleoside Analog
3,5-Di-O-benzoyl-2-deoxy-2-fluoro-5-trifluoromethyl-arabinouridine is a purine nucleoside analog that exhibits significant antitumor activity. Its mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool in cancer research, particularly for targeting indolent lymphoid malignancies. This compound is suitable for studies focused on cancer treatment and the development of novel therapeutic strategies. -
Purine Nucleoside Analog
N1-Methyl ara-uridine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research. This compound can be utilized to explore therapeutic approaches in various malignancies and enhance understanding of nucleoside analog efficacy. -
Purine Nucleoside Analog
3’-Deoxy-3’-fluoro-xyloadenosine is a purine nucleoside analog that exhibits significant antitumor activity, particularly in the treatment of indolent lymphoid malignancies. This compound acts through mechanisms such as the inhibition of DNA synthesis and the induction of apoptosis. Its applications in cancer research make it a valuable tool for exploring therapeutic strategies against various hematological cancers. -
Nucleoside Analogue
Methyl 2-deoxy-3,5-di-O-benzoyl-2-fluoro-4-thio-beta-D-arabinopentofuranoside is a nucleoside analogue targeting viral nucleic acid synthesis. This compound exhibits potential antiviral activity and is utilized in research related to viral infections and nucleoside-related pathways. Its structural modifications make it a valuable tool in exploring the mechanisms of nucleic acid function and inhibition in biological systems. -
Purine Nucleoside Analog
2-Amino-1-β-D-arabinofuranosyl-5-methyl-4(1H)-pyrimidinone is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanism involves the inhibition of DNA synthesis, which contributes to the induction of apoptosis in cancer cells. This compound is valuable for research applications centered on cancer biology and therapeutic development. -
Purine Nucleoside Analog
2’,3’,5’-Tri-O-benzyl-4’-thio-arabinouridine is a purine nucleoside analog that demonstrates significant antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis. This compound serves as a valuable tool for research applications focused on cancer biology and the development of therapeutic strategies for lymphoid cancers. -
Purine Nucleoside Analog
5’-O-(p-Toluoyl)-2’-O-acetyl-3’-deoxy-3’-fluoro-6-chloroinosine is a purine nucleoside analog that exhibits significant antitumor activity, targeting indolent lymphoid malignancies. Its mechanism of action involves the inhibition of DNA synthesis and the induction of apoptosis in cancer cells. This reagent is useful in cancer research, particularly in studies aimed at understanding the efficacy of nucleotide analogs in therapeutic applications. -
Purine Nucleoside Analog
6-Aza-2'-deoxyuridine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanism involves the inhibition of DNA synthesis, leading to the induction of apoptosis in cancer cells. This compound is valuable for research applications focused on cancer biology and therapeutic development targeting nucleotide metabolism pathways. -
Radiosensitizer
RA-263 is a 2-nitroimidazole nucleoside that functions as a radiosensitizer. This compound enhances the efficacy of radiation therapy by increasing the sensitivity of tumor cells to ionizing radiation. RA-263 is primarily utilized in cancer research to investigate combined modality treatments and to explore mechanisms of radioresistance in various tumor models. -
Purine Nucleoside Analog
2-Amino-6-chloropurine-9-beta-D-(2'-deoxy-2'-fluoro)-arabinoriboside is a purine nucleoside analog that exerts its primary effects by inhibiting DNA synthesis. This compound demonstrates significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanism of action includes the induction of apoptosis, making it a valuable tool for research in cancer biology and therapeutic development. -
Purine Nucleoside Analog
2’-β-C-Methyl-2-thiouridine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool in cancer research. This compound is utilized to explore therapeutic strategies for various malignancies and to study the role of nucleoside analogs in cancer treatment. -
Guanosine Analog
N2-iso-Butyroyl-5'-O-DMT-3'-deoxy-3'-fluoroguanosine is a guanosine analog that acts primarily through the activation of Toll-like receptor 7 (TLR7). This compound exhibits immunostimulatory properties and has been demonstrated to induce type I interferons in various animal models, leading to antiviral effects. It is a valuable tool for research in virology and immunology, facilitating investigations into host responses to viral infections and the modulation of immune pathways. -
Cytidine Analog
N4-Benzoyl-5'-O-DMT-5-methylcytidine is a cytidine analog that primarily targets DNA methyltransferases, thereby inhibiting their activity. This compound exhibits potential anti-metabolic and anti-tumor properties, making it valuable in cancer research and studies focused on epigenetic regulation. Its ability to modulate DNA methylation provides avenues for investigating therapeutic strategies against malignancies. -
Purine Nucleoside Analog
4′,5′-Didehydro-5′-deoxy-5-methyluridine is a purine nucleoside analog with significant antitumor properties. This compound exhibits its anticancer effects primarily through the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool in the study of indolent lymphoid malignancies. Its use in research can facilitate the understanding of nucleoside metabolism and the development of therapeutic strategies in cancer treatment. -
Nucleoside Metabolite
Bis(glutathionyl)spermine disulfide is a nucleoside metabolite that plays a crucial role in cellular redox balance. This compound is known for its ability to regulate cellular antioxidant systems and modulate intracellular signaling pathways. It is primarily used in research applications focusing on oxidative stress, cell proliferation, and apoptosis mechanisms. -
Purine Nucleoside Analog
3’-Deoxy-1,2-O-isopropylidene-5-O-(p-toluoyl)-L-arabinofuranose is a purine nucleoside analog that inhibits DNA synthesis and induces apoptosis. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. It serves as a valuable tool in cancer research and therapeutic development. -
Coenzyme A Analog
3a,7a,12a-Trihydroxy-5b-24-oxocholestanoyl-CoA is a coenzyme A analog that serves as a crucial substrate in the investigation of β-oxidation processes specific to bile acid biosynthesis. This compound enables researchers to explore metabolic pathways and enzyme activities associated with cholesterol derivatives. Its utility in biochemical assays makes it a valuable tool for studies focused on lipid metabolism and biosynthetic regulation. -
Purine Nucleoside Analog
6-Methyl-9-(β-D-xylofuranosyl)purine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer mechanisms involve the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool in cancer research. This compound plays a critical role in investigating the therapeutic potential of nucleoside analogs in oncology and related fields. -
Purine Nucleoside Analog
(R)-5-O-Benzoyl-1,2-di-O-isopropylidene-alpha-D-xylofuranose is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanism involves the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool in cancer research. This compound is suited for investigations into therapeutic strategies targeting nucleoside metabolism and cancer cell proliferation. -
Adenosine Analog
2-(N,N-Dimethylamino)-N6,N6-dimethyladenosine is an adenosine analog that functions primarily as a smooth muscle vasodilator. This compound has demonstrated potential in inhibiting cancer progression, making it a valuable tool for research in vascular biology and oncology. It can be utilized in studies exploring the pharmacological effects of adenosine derivatives and their therapeutic applications. -
Nucleoside Metabolite
Pretyrosine, also known as L-Arogenic acid or L-Arogenate, functions as a nucleoside metabolite. This compound plays a significant role in the biosynthesis of amino acids and serves as a key intermediate in the production of various bioactive molecules. Pretyrosine is primarily utilized in research applications focusing on metabolic pathways, enzymatic activities, and the synthesis of secondary metabolites in plants and microorganisms. -
Purine Nucleoside Analog
2-Amino-3’-O-methyladenosine is a purine nucleoside analog known for its broad antitumor activity, particularly against indolent lymphoid malignancies. This compound exerts its anticancer effects primarily through the inhibition of DNA synthesis and the induction of apoptosis. It serves as a valuable tool in cancer research, facilitating the investigation of therapeutic strategies targeting nucleoside metabolism and cellular proliferation pathways. -
Thymidine Analog
5-Methoxymethyluridine is a thymidine analog that incorporates into replicated DNA, exhibiting insertional activity. This compound is employed as a labeling agent in cellular studies, facilitating the tracking of DNA synthesis. Its unique properties make it valuable for research applications in molecular biology and genetics. -
Thymidine Analog
5-Hydroxymethyl-2’-β-C-methyluridine is a thymidine analog that exhibits insertional activity towards replicated DNA. This compound can be utilized to label cells and monitor DNA synthesis, making it valuable for studies in cell proliferation, genetics, and molecular biology. Its unique structural properties facilitate the investigation of nucleic acid dynamics and cellular processes related to DNA replication. -
Purine Nucleoside Analog
1,2,4-Triazine-3,5-dione 2-β-D-xylopyranoside is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its biological activity is primarily mediated through the inhibition of DNA synthesis and the induction of apoptosis in cancer cells. This compound serves as a valuable tool in cancer research, providing insights into therapeutic strategies targeting nucleoside metabolism and tumor cell proliferation. -
Pyrimidine Nucleoside Analog
6-Amino-4-methoxy-1-(2-deoxy-β-D-ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidine is a pyrimidine nucleoside analog that targets nucleotide metabolism. This compound exhibits significant biological activities, including the inhibition of DNA and RNA synthesis, as well as antiviral and immunomodulatory effects. It serves as a valuable tool in biochemical research and the development of therapeutic agents, particularly in the study of cancer and viral infections. -
Purine Nucleoside Analog
5’-Deoxy-N4,N4-dimethyl-5-fluorocytidine is a purine nucleoside analog that selectively targets cellular processes involved in DNA synthesis. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies, by inhibiting DNA replication and inducing apoptosis in cancer cells. It is a valuable tool for research in oncology, facilitating the understanding of cancer cell biology and treatment responses. -
Adenosine Analog
N6-Aminoadenosine is an adenosine analogue that primarily functions as a smooth muscle vasodilator. Its biological activity includes the inhibition of cancer progression, making it a valuable tool in cancer research. N6-Aminoadenosine can be utilized in various studies focused on cardiovascular dynamics and tumor biology, providing insights into the therapeutic potentials of adenosine-related compounds. -
Purine Nucleoside Analog
2-Chloro-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-6-methoxy-9H-purine is a purine nucleoside analog that exhibits broad antitumor activity against indolent lymphoid malignancies. Its primary mechanisms involve the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research and therapeutic development. This compound is suitable for studies focused on enhancing understanding of tumor biology and evaluating potential treatment strategies. -
Adenosine Analog
N-[(3-Methoxyphenyl)methyl]adenosine is an adenosine analog that primarily targets adenosine receptors. This compound exhibits significant biological activity as a smooth muscle vasodilator and has demonstrated potential in inhibiting cancer progression. It is a valuable tool for researchers investigating vascular biology and cancer therapeutics. -
Cytidine Analog
N4-Benzoyl-3'-O-methylcytidine is a cytidine analog that inhibits DNA methyltransferases, disrupting DNA methylation patterns. This compound exhibits potential anti-metabolic and anti-tumor activities, making it a valuable tool for cancer research. It can be utilized in studies aimed at understanding epigenetic modifications and their implications in various biological processes. -
Dideoxynucleotide
ddTTPαS is a dideoxynucleotide that serves as a sulfur-containing nucleoside triphosphate derivative. It is primarily used for chain termination during DNA synthesis, making it a valuable tool in PCR assays and other molecular biology applications. Its unique chemical structure allows for precise modification of nucleic acid sequences, facilitating studies in genetic research and diagnostics. -
Purine Nucleoside Analog
2-Chloro-6-(furan-2-yl) purine-beta-D-(3’-deoxy-3’-fluoro)-riboside is a purine nucleoside analog that exerts potent antitumor activity, particularly against indolent lymphoid malignancies. Its mechanism of action includes the inhibition of DNA synthesis and the induction of apoptosis in cancer cells, making it a valuable tool for research in cancer biology and therapeutic development. This compound is suitable for exploring cellular responses to nucleoside analogs and their potential applications in cancer treatment. -
Purine Nucleoside Analog
N1-Ethylpseudouridine is a purine nucleoside analogue that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanism involves the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research. This compound is useful for studies focused on the development of therapeutic strategies targeting purine metabolism and nucleoside analogs in oncology. -
Adenosine Analog
5’-O-(4,4’-Dimethoxytrityl)-2’-O-(2-methoxyethyl) adenosine is an adenosine analog that primarily targets adenosine receptors. This compound demonstrates biological activities such as smooth muscle vasodilation and potential inhibition of cancer progression. It is valuable for research in cardiovascular studies and cancer biology, facilitating investigations into adenosine signaling and therapeutic applications. -
Purine Nucleoside Analog
2'-Amino-2'-deoxy-5-methylcytidine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanism involves the inhibition of DNA synthesis and the induction of apoptosis in cancer cells. This compound is valuable for research applications focused on understanding cancer biology and the development of novel therapeutic strategies. -
Purine Nucleoside Analog
1-Amino-3’-deoxy-7,8-dihydro-8-oxoguanosine is a purine nucleoside analog that primarily targets nucleic acid synthesis. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies, through mechanisms such as the inhibition of DNA synthesis and the induction of apoptosis. It is a valuable reagent for researchers investigating the therapeutic potential of nucleoside analogs in cancer treatment. -
Purine Nucleoside Analog
2'-β-C-Methyl-5-methoxyuridine is a purine nucleoside analog with significant antitumor activity. It primarily targets indolent lymphoid malignancies, exerting its effects through the inhibition of DNA synthesis and the induction of apoptosis. This compound is valuable for research applications focused on cancer biology and therapeutic development. -
Purine Nucleoside Analog
5,6-Dihydro-ara-uridine is a purine nucleoside analog known for its broad antitumor activity, particularly against indolent lymphoid malignancies. This compound primarily exerts its anticancer effects through the inhibition of DNA synthesis and the induction of apoptosis. It serves as a valuable research tool in the study of cancer therapeutics and cellular mechanisms related to purine metabolism. -
Purine Nucleoside Analog
2-Amino-6-chloro-9-(2-β-C-methyl-β-D-ribofuranosyl)-9H-purine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanisms of action involve the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool in cancer research. This compound is utilized for exploring therapeutic strategies in oncology and can aid in the development of novel treatments for hematological cancers. -
Purine Nucleoside Analog
8-Aza-7-bromo-7-deazaguanosine is a purine nucleoside analog that effectively targets DNA synthesis pathways. It exhibits significant antitumor activity, particularly in the context of indolent lymphoid malignancies, by inducing apoptosis and disrupting cellular proliferation. This compound is valuable for researchers investigating mechanisms of cancer treatment and the role of nucleoside analogs in therapeutic applications. -
Purine Nucleoside Analog
2’-Deoxy-2’-fluoro-4-thio-beta-D-arabinouridine is a purine nucleoside analogue that exhibits significant anticancer properties. This compound primarily targets and inhibits DNA synthesis, leading to the induction of apoptosis in cancer cells. It is particularly relevant for research on indolent lymphoid malignancies, offering insights into potential therapeutic strategies for various types of cancer. -
Purine Nucleoside Analog
3-Deoxy-1,2-O-isopropylidene-5-p-toluoyl-a-D-glycero-pent-3-enofuranose is a purine nucleoside analog that interferes with DNA synthesis in cancer cells. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies, by inducing apoptosis and disrupting cellular proliferation. It serves as a valuable tool for research focused on cancer biology and therapeutic development. -
Tryptamine Product
N-Hydroxyl-tryptamine is a tryptamine derivative synthesized through the action of flavin monooxygenase (FMO). This compound serves as a pivotal intermediate in the biosynthesis of various biologically active molecules. It is utilized in research applications focusing on neurochemistry, pharmacology, and the elucidation of serotonin-related pathways.
